Banisteriopsis
Ethnopharmacology
Harmine
Proanthocyanidins
Plant Stems
Monoamine Oxidase
Beverages
Neurodegenerative Diseases
Catechin
Alkaloids
Plant Leaves
Reference Standards
Parkinson Disease
Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. (1/7)
AIMS: Ayahuasca is a traditional South American psychoactive beverage used in Amazonian shamanism, and in the religious ceremonies of Brazilian-based syncretic religious groups with followers in the US and several European countries. This tea contains measurable amounts of the psychotropic indole N,N-dimethyltryptamine (DMT), and beta-carboline alkaloids with MAO-inhibiting properties. In a previous report we described a profile of stimulant and psychedelic effects for ayahuasca as measured by subjective report self-assessment instruments. In the present study the cerebral bioavailability and time-course of effects of ayahuasca were assessed in humans by means of topographic quantitative-electroencephalography (q-EEG), a noninvasive method measuring drug-induced variations in brain electrical activity. METHODS: Two doses (one low and one high) of encapsulated freeze-dried ayahuasca, equivalent to 0.6 and 0.85 mg DMT kg(-1) body weight, were administered to 18 healthy volunteers with previous experience in psychedelic drug use in a double-blind crossover placebo-controlled clinical trial. Nineteen-lead recordings were undertaken from baseline to 8 h after administration. Subjective effects were measured by means of the Hallucinogen Rating Scale (HRS). RESULTS: Ayahuasca induced a pattern of psychoactive effects which resulted in significant dose-dependent increases in all subscales of the HRS, and in significant and dose-dependent modifications of brain electrical activity. Absolute power decreased in all frequency bands, most prominently in the theta band. Mean absolute power decreases (95% CI) at a representative lead (P3) 90 min after the high dose were -20.20+/-15.23 microV2 and -2.70+/-2.21 microV2 for total power and theta power, respectively. Relative power decreased in the delta (-1.20+/-1.31% after 120 min at P3) and theta (-3.30+/-2.59% after 120 min at P3) bands, and increased in the beta band, most prominently in the faster beta-3 (1.00+/-0.88% after 90 min at P3) and beta-4 (0.30+/-0.24% after 90 min at P3) subbands. Finally, an increase was also seen for the centroid of the total activity and its deviation. EEG modifications began as early as 15-30 min, reached a peak between 45 and 120 min and decreased thereafter to return to baseline levels at 4-6 h after administration. CONCLUSIONS: The central effects of ayahuasca could be objectively measured by means of q-EEG, showing a time pattern which closely paralleled that of previously reported subjective effects. The modifications seen for the individual q-EEG variables were in line with those previously described for other serotonergic psychedelics and share some features with the profile of effects shown by pro-serotonergic and pro-dopaminergic drugs. The q-EEG profile supports the role of 5-HT2 and dopamine D2-receptor agonism in mediating the effects of ayahuasca on the central nervous system. (+info)Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. (2/7)
The effects of the South American psychotropic beverage ayahuasca on subjective and cardiovascular variables and urine monoamine metabolite excretion were evaluated, together with the drug's pharmacokinetic profile, in a double-blind placebo-controlled clinical trial. This pharmacologically complex tea, commonly obtained from Banisteriopsis caapi and Psychotria viridis, combines N,N-dimethyltryptamine (DMT), an orally labile psychedelic agent showing 5-hydroxytryptamine2A agonist activity, with monoamine oxidase (MAO)-inhibiting beta-carboline alkaloids (harmine, harmaline, and tetrahydroharmine). Eighteen volunteers with prior experience in the use of psychedelics received single oral doses of encapsulated freeze-dried ayahuasca (0.6 and 0.85 mg of DMT/kg of body weight) and placebo. Ayahuasca produced significant subjective effects, peaking between 1.5 and 2 h, involving perceptual modifications and increases in ratings of positive mood and activation. Diastolic blood pressure showed a significant increase at the high dose (9 mm Hg at 75 min), whereas systolic blood pressure and heart rate were moderately and nonsignificantly increased. Cmax values for DMT after the low and high ayahuasca doses were 12.14 ng/ml and 17.44 ng/ml, respectively. Tmax (median) was observed at 1.5 h after both doses. The Tmax for DMT coincided with the peak of subjective effects. Drug administration increased urinary normetanephrine excretion, but, contrary to the typical MAO-inhibitor effect profile, deaminated monoamine metabolite levels were not decreased. This and the negligible harmine plasma levels found suggest a predominantly peripheral (gastrointestinal and liver) site of action for harmine. MAO inhibition at this level would suffice to prevent first-pass metabolism of DMT and allow its access to systemic circulation and the central nervous system. (+info)A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. (3/7)
A case of a 25-year-old white male who was found dead the morning after consuming herbal extracts containing beta-carbolines and hallucinogenic tryptamines is presented. No anatomic cause of death was found at autopsy. Toxicologic analysis of the heart blood identified N,N-dimethyltryptamine (0.02 mg/L), 5-methoxy-N,N-dimethyltryptamine (1.88 mg/L), tetrahydroharmine (0.38 mg/L), harmaline (0.07 mg/L), and harmine (0.17 mg/L). All substances were extracted by a single-step n-butyl chloride extraction following alkalinization with borate buffer. Detection and quantitation was performed using liquid chromatography-electrospray mass spectrometry. The medical examiner ruled that the cause of death was hallucinogenic amine intoxication, and the manner of death was undetermined. (+info)Ayahuasca versus violence--a case report. (4/7)
We have limited resources available for the treatment and prevention of violent behavior. The usefulness of the most commonly used medications, namely the selective serotonin-reuptake inhibitor [SSRI] agents for the above purpose is a debated issue in the psychiatric literature. The aim of this case report is to add an ethnopharmacological perspective to the management of human aggression. Particularly, attention is called to the potential prosocial effect of the Amazonian beverage, ayahuasca--a decoctum, which has been used traditionally for multiple medico-religious purposes by numerous indigenous groups of the Upper Amazon--and has been found to be useful in crisis intervention, achieving redemption, as well as eliciting cathartic feelings with moral content. (+info)Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease. (5/7)
(+info)Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease. (6/7)
(+info)Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study. (7/7)
(+info)Banisteriopsis is a genus of flowering plants in the family Malpighiaceae, native to tropical America. The most well-known species is Banisteriopsis caapi, which is used to prepare a psychoactive beverage called ayahuasca, also known as yage. Ayahuasca is traditionally used for spiritual and religious purposes by indigenous peoples of the Amazon basin.
The active components in Banisteriopsis caapi are harmala alkaloids, including harmine, harmaline, and tetrahydroharmine, which act as reversible inhibitors of monoamine oxidase (MAOIs). When combined with DMT-containing plants, such as Psychotria viridis, the MAOIs allow the DMT to be orally active, resulting in a powerful psychedelic experience.
It is important to note that the use of ayahuasca and other substances containing DMT and MAOIs can have serious health consequences and should only be undertaken under the guidance of experienced practitioners in a safe and controlled setting.
Ethnopharmacology is a branch of pharmacology that focuses on the study of traditional medicines and their active components, as well as the cultural, historical, and social practices surrounding their use. It involves the interdisciplinary investigation of indigenous knowledge, beliefs, and customs related to medicinal plants and other natural remedies.
The main objectives of ethnopharmacology include:
1. Identifying and documenting traditional medicines and healing practices used by various cultures around the world.
2. Investigating the pharmacological properties and mechanisms of action of these traditional remedies, often through laboratory experiments and clinical trials.
3. Evaluating the safety, efficacy, and quality of traditional medicines to establish their potential therapeutic value in modern healthcare settings.
4. Promoting the sustainable use of natural resources and preserving indigenous knowledge and cultural heritage related to traditional medicine.
5. Fostering collaboration between scientists, healthcare professionals, and local communities to develop new drugs, therapies, and treatment approaches based on traditional medicines.
Examples of ethnopharmacological research include studying the active ingredients in Ayurvedic herbs, evaluating the effectiveness of Traditional Chinese Medicine (TCM) formulations, and investigating the potential benefits of psychoactive plants used in shamanic rituals.
Harmane, also known as harmaline, is a naturally occurring psychoactive compound found in several plants, including the seeds of the Syrian rue (Peganum harmala) and the bark of the African pinwheel cactus (Adenium obesum). It is an alkaloid with beta-carboline structure.
In a medical context, harmaline has been studied for its potential effects on the central nervous system. It acts as a reversible monoamine oxidase inhibitor (MAOI), which means it can increase the levels of certain neurotransmitters in the brain by preventing their breakdown. This property has led to some research into its use as a treatment for depression and other neurological disorders, although it is not currently approved for medical use in this capacity due to potential side effects and toxicity concerns.
It's important to note that harmaline can have dangerous interactions with certain medications and foods, particularly those containing tyramine, which can lead to a hypertensive crisis. Therefore, its use should only be under the supervision of a qualified medical professional.
Harmine is defined medically as an alpha-carboline derivative that is present in various plants including the seeds of Peganum harmala and the bark of Banisteriopsis caapi. It functions as an monoamine oxidase inhibitor (MAOI) and has been used in traditional medicine for its psychoactive properties. It has also been studied for potential anti-cancer, anti-inflammatory, and neuroprotective effects.
Biflavonoids are a type of flavonoid, which are plant-based compounds with antioxidant properties. Biflavonoids are unique because they consist of two flavonoid molecules joined together. They can be found in various plants, including fruits, vegetables, and herbs. Some research suggests that biflavonoids may have potential health benefits, such as reducing inflammation and protecting against oxidative stress. However, more research is needed to confirm these effects and determine the optimal dosages for human consumption.
Aerial parts of plants refer to the above-ground portions of a plant, including leaves, stems, flowers, and fruits. These parts are often used in medicine, either in their entirety or as isolated extracts, to take advantage of their medicinal properties. The specific components of aerial parts that are used in medicine can vary depending on the plant species and the desired therapeutic effects. For example, the leaves of some plants may contain active compounds that have anti-inflammatory or analgesic properties, while the flowers of others may be rich in antioxidants or compounds with sedative effects. In general, aerial parts of plants are used in herbal medicine to treat a wide range of conditions, including respiratory, digestive, and nervous system disorders, as well as skin conditions and infections.
Proanthocyanidins are a type of polyphenolic compound that are found in various plants, including fruits, vegetables, and bark. They are also known as condensed tannins or oligomeric procyanidins (OPCs). These compounds are characterized by their ability to form complex structures through the linkage of flavan-3-ol units.
Proanthocyanidins have been studied for their potential health benefits, which may include antioxidant, anti-inflammatory, and cardiovascular protective effects. They have also been shown to have a positive impact on collagen stability, which may contribute to their potential role in promoting skin and joint health.
Foods that are rich in proanthocyanidins include grapes (and red wine), berries, apples, cocoa, and green tea. These compounds can be difficult for the body to absorb, but supplements containing standardized extracts of proanthocyanidins are also available.
It's important to note that while proanthocyanidins have shown promise in laboratory and animal studies, more research is needed to fully understand their potential health benefits and safety profile in humans. As with any supplement, it's always a good idea to talk to your healthcare provider before starting to take proanthocyanidins.
A plant stem is not typically defined in a medical context, but rather in the field of botany. However, I can certainly provide a general biological definition for you.
In plants, stems are organs that serve primarily as support structures, holding leaves, flowers, and fruits aloft where they can receive sunlight and exchange gases. They also act as conduits, transporting water, nutrients, and sugars made during photosynthesis between the roots and shoots of a plant.
The stem is usually composed of three main tissue systems: dermal, vascular, and ground. The dermal tissue system forms the outermost layer(s) of the stem, providing protection and sometimes participating in gas exchange. The vascular tissue system contains the xylem (which transports water and nutrients upward) and phloem (which transports sugars and other organic compounds downward). The ground tissue system, located between the dermal and vascular tissues, is responsible for food storage and support.
While not a direct medical definition, understanding the structure and function of plant stems can be relevant in fields such as nutrition, agriculture, and environmental science, which have implications for human health.
Monoamine oxidase (MAO) is an enzyme found on the outer membrane of mitochondria in cells throughout the body, but primarily in the gastrointestinal tract, liver, and central nervous system. It plays a crucial role in the metabolism of neurotransmitters and dietary amines by catalyzing the oxidative deamination of monoamines. This enzyme exists in two forms: MAO-A and MAO-B, each with distinct substrate preferences and tissue distributions.
MAO-A preferentially metabolizes serotonin, norepinephrine, and dopamine, while MAO-B is mainly responsible for breaking down phenethylamines and benzylamines, as well as dopamine in some cases. Inhibition of these enzymes can lead to increased neurotransmitter levels in the synaptic cleft, which has implications for various psychiatric and neurological conditions, such as depression and Parkinson's disease. However, MAO inhibitors must be used with caution due to their potential to cause serious adverse effects, including hypertensive crises, when combined with certain foods or medications containing dietary amines or sympathomimetic agents.
A beverage is a drink intended for human consumption. The term is often used to refer to any drink that is not alcoholic or, in other words, non-alcoholic beverages. This includes drinks such as water, juice, tea, coffee, and soda. However, it can also include alcoholic drinks like beer, wine, and spirits.
In a medical context, beverages are often discussed in relation to their impact on health. For example, sugary drinks like soda and energy drinks have been linked to obesity, diabetes, and other health problems. On the other hand, drinks like water and unsweetened tea can help to keep people hydrated and may have other health benefits.
It's important for individuals to be mindful of their beverage choices and to choose options that are healthy and support their overall well-being. This may involve limiting sugary drinks, choosing water or unsweetened tea instead of soda, and avoiding excessive caffeine intake.
Neurodegenerative diseases are a group of disorders characterized by progressive and persistent loss of neuronal structure and function, often leading to cognitive decline, functional impairment, and ultimately death. These conditions are associated with the accumulation of abnormal protein aggregates, mitochondrial dysfunction, oxidative stress, chronic inflammation, and genetic mutations in the brain. Examples of neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis (ALS), and Spinal Muscular Atrophy (SMA). The underlying causes and mechanisms of these diseases are not fully understood, and there is currently no cure for most neurodegenerative disorders. Treatment typically focuses on managing symptoms and slowing disease progression.
A catechin is a type of plant phenol and antioxidant found in various foods and beverages, such as tea, cocoa, and certain fruits and vegetables. Chemically, catechins are flavan-3-ols, which are a subclass of flavonoids. They have several potential health benefits, including reducing the risk of cardiovascular disease, cancer, and neurodegenerative disorders.
Catechins are known to have anti-inflammatory, antimutagenic, and antidiabetic properties. They can also help improve oral health by inhibiting the growth of harmful bacteria in the mouth. The most well-known catechin is epigallocatechin gallate (EGCG), which is found in high concentrations in green tea and has been extensively studied for its potential health benefits.
In summary, a catechin is a type of antioxidant compound found in various plant-based foods and beverages that may have several health benefits, including reducing the risk of chronic diseases and improving oral health.
Alkaloids are a type of naturally occurring organic compounds that contain mostly basic nitrogen atoms. They are often found in plants, and are known for their complex ring structures and diverse pharmacological activities. Many alkaloids have been used in medicine for their analgesic, anti-inflammatory, and therapeutic properties. Examples of alkaloids include morphine, quinine, nicotine, and caffeine.
I believe there may be a slight misunderstanding in your question. "Plant leaves" are not a medical term, but rather a general biological term referring to a specific organ found in plants.
Leaves are organs that are typically flat and broad, and they are the primary site of photosynthesis in most plants. They are usually green due to the presence of chlorophyll, which is essential for capturing sunlight and converting it into chemical energy through photosynthesis.
While leaves do not have a direct medical definition, understanding their structure and function can be important in various medical fields, such as pharmacognosy (the study of medicinal plants) or environmental health. For example, certain plant leaves may contain bioactive compounds that have therapeutic potential, while others may produce allergens or toxins that can impact human health.
Reference standards in a medical context refer to the established and widely accepted norms or benchmarks used to compare, evaluate, or measure the performance, accuracy, or effectiveness of diagnostic tests, treatments, or procedures. These standards are often based on extensive research, clinical trials, and expert consensus, and they help ensure that healthcare practices meet certain quality and safety thresholds.
For example, in laboratory medicine, reference standards may consist of well-characterized samples with known concentrations of analytes (such as chemicals or biological markers) that are used to calibrate instruments and validate testing methods. In clinical practice, reference standards may take the form of evidence-based guidelines or best practices that define appropriate care for specific conditions or patient populations.
By adhering to these reference standards, healthcare professionals can help minimize variability in test results, reduce errors, improve diagnostic accuracy, and ensure that patients receive consistent, high-quality care.
Parkinson's disease is a progressive neurodegenerative disorder that affects movement. It is characterized by the death of dopamine-producing cells in the brain, specifically in an area called the substantia nigra. The loss of these cells leads to a decrease in dopamine levels, which results in the motor symptoms associated with Parkinson's disease. These symptoms can include tremors at rest, stiffness or rigidity of the limbs and trunk, bradykinesia (slowness of movement), and postural instability (impaired balance and coordination). In addition to these motor symptoms, non-motor symptoms such as cognitive impairment, depression, anxiety, and sleep disturbances are also common in people with Parkinson's disease. The exact cause of Parkinson's disease is unknown, but it is thought to be a combination of genetic and environmental factors. There is currently no cure for Parkinson's disease, but medications and therapies can help manage the symptoms and improve quality of life.